EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

A Comparative Genomic Study of Conventional and Undifferentiated Melanoma

Grant M Fischer, Navin R Mahadevan, Jason L Hornick, Christopher D M Fletcher, Eleanor Russell-Goldman

Modern Pathology · 2024

DOI: 10.1016/j.modpat.2024.100626 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Modern Pathology, 2024. Verfasst von Grant M Fischer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Mutation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Dana-Farber Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Undifferentiated melanoma, defined as melanoma that has lost all usual phenotypic and immunohistochemical characteristics of conventional melanoma, can pose significant diagnostic challenges. Molecular studies have advanced our understanding of undifferentiated melanoma by demonstrating that a subset of these tumors harbors known melanoma driver alterations in genes such as BRAF, NRAS, and NF1. However, there is a paucity of data describing genetic alterations that may distinguish undifferentiated melanoma from conventional melanoma. In this study, we directly compared the genomic profiles of undifferentiated melanoma to a cohort of conventional melanomas, including 14 undifferentiated melanoma cases (comprised of 2 primary cases, 2 cutaneous recurrences, and 10 metastases) and a cohort of 127 conventional melanomas including primary, recurrent, and metastatic cases. Targeted sequencing of 447 cancer-associated genes was performed, including identification of mutations and copy number alterations. NRAS was the most frequent melanoma driver in undifferentiated melanoma (8/14 cases, 57%), although notably, only 1 undifferentiated melanoma harbored an NRAS Q61R mutation. Compared with the conventional melanoma cohort, undifferentiated melanoma demonstrated statistically significant enrichment of pathogenic activating RAC1 mutations (6/14 total cases, 43%), including P29S (4/6 cases), P29L (1/6 cases), and D11E (1/6 cases). In addition to providing insight into the molecular pathogenesis of undifferentiated melanoma, these findings also suggest that RAS Q61R immunohistochemistry may have limited utility for its diagnosis. The presence of recurrent RAC1 mutations in undifferentiated melanoma is also notable as these alterations may contribute to mitogen-activated protein kinase pathway-targeted therapy resistance. Furthermore, the RAC1 alterations identified in this cohort have been shown to drive a melanocytic to mesenchymal switch in melanocytes, offering a possible explanation for the undifferentiated phenotype of these melanomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsMutationHumansMaleFemaleMiddle AgedAgedAdultAged, 80 and overGenomicsBiomarkers, TumorGTP PhosphohydrolasesDNA Copy Number VariationsMembrane Proteins

Stichwörter der Autor:innen

NRASRAC1genetic alterationsundifferentiated melanoma

Substanzen

Biomarkers, TumorGTP PhosphohydrolasesNRAS protein, humanMembrane Proteins

Autor:innen und Institutionen

  • Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: erussell-goldman@bwh.harvard.edu.

Förderung

  • NCI NIH HHS
  • Dana-Farber Cancer Institute

Zitieren

APA

Fischer, G. M., Mahadevan, N. R., Hornick, J. L., Fletcher, C. D. M., & Russell-Goldman, E. (2024). A Comparative Genomic Study of Conventional and Undifferentiated Melanoma. Modern Pathology. https://doi.org/10.1016/j.modpat.2024.100626

Vancouver

Fischer GM, Mahadevan NR, Hornick JL, Fletcher CDM, Russell-Goldman E. A Comparative Genomic Study of Conventional and Undifferentiated Melanoma. Modern Pathology. 2024. doi:10.1016/j.modpat.2024.100626

BibTeX
@article{Fischer2024,
  author = {Fischer, Grant M and Mahadevan, Navin R and Hornick, Jason L and Fletcher, Christopher D M and Russell-Goldman, Eleanor},
  title = {A Comparative Genomic Study of Conventional and Undifferentiated Melanoma},
  journal = {Modern Pathology},
  year = {2024},
  doi = {10.1016/j.modpat.2024.100626}
}
Kostenlos starten →